No Data
No Data
Kaisai Biotech (688065): 24Q1 performance, year-on-month recovery in demand for long-chain binary acid recovery
Incident: 1) The company achieved revenue of 2,114 billion yuan in 2023, -13.39%; realized net profit to mother of 367 million yuan, or -33.75% year on year; realized net profit after deduction of 307 million yuan, YoY-
Kaiser Biotech (688065): Significant increase in first-quarter results, imminent release of bio-based polyamides
Description of the incident On April 30, 2024, Kaiser Biotech released its 2023 Annual Report and 2024 Quarterly Report. The company achieved revenue of 2,114 billion yuan in 2023, a year-on-year decrease of 13.39%;
Cathay Biotech (688065): Demand for long-chain binary acids is picking up, Q1 performance is high year-on-month, and bio-based composites accelerate commercial application implementation
Key investment points: The company released its 2023 annual report: During the reporting period, the company achieved revenue of 21.14 billion yuan (YoY -13%), achieved net profit attributable to mother of 367 million yuan (YoY -34%), and achieved net profit deducted from non-mother 3
Cathay Biotech (688065.SH) announced first-quarter results, net profit of 105 million yuan, up 83.25% year-on-year
Cathay Biotech (688065.SH) disclosed its report for the first quarter of 2024. The company achieved operating revenue during the reporting period...
Kaisai Biotech (688065): Q1 performance increased significantly over the same period last month and continued to advance
Core view The company achieved significant improvements in revenue and profit margins in the first quarter, and downstream demand began to pick up; it is anticipated that subsequent sebacic acid projects will gradually expand as overseas customers develop, the Q1 inflection point will be established, and the company's performance growth will continue. Furthermore,
Shareholders of Kaisai Biotech (688065.SH) Tianjin Sitong and Seasource reduced their holdings of the company by 1.1%
Cathay Biotech (688065.SH) issued an announcement. The company received the shareholder Tianjin Sitong on April 22, 2024...
No Data